Valvular	valvular	O	DISEASE	OTHERS	I
heart	heart	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
treated	treated	O	O	O	O
with	with	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Course	course	O	O	O	O
following	following	O	O	O	O
treatment	treatment	O	O	O	O
modifications	modifications	O	O	O	O
.	.	O	O	O	O

Valvular	valvular	O	O	OTHERS	I
heart	heart	O	O	OTHERS	I
abnormalities	abnormalities	O	O	OTHERS	I
have	have	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
(	(	O	O	O	O
PD	pd	O	DISEASE	OTHERS	I
)	)	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
and	and	O	O	O	O
severity	severity	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
abnormalities	abnormalities	O	O	O	O
vary	vary	O	O	O	O
from	from	O	O	O	O
study	study	O	O	O	O
to	to	O	O	O	O
study	study	O	O	O	O
and	and	O	O	O	O
their	their	O	O	O	O
course	course	O	O	O	O
after	after	O	O	O	O
drug	drug	O	O	O	O
withdrawal	withdrawal	O	O	O	O
has	has	O	O	O	O
not	not	O	O	O	O
been	been	O	O	O	O
systematically	systematically	O	O	O	O
assessed	assessed	O	O	O	O
.	.	O	O	O	O

OBJECTIVES	objectives	O	O	O	O
:	:	O	O	O	O
To	to	O	O	O	O
estimate	estimate	O	O	O	O
the	the	O	O	O	O
frequency	frequency	O	O	O	O
and	and	O	O	O	O
severity	severity	O	O	O	O
of	of	O	O	O	O
valvular	valvular	O	O	OTHERS	I
heart	heart	O	O	OTHERS	I
abnormality	abnormality	O	O	OTHERS	I
and	and	O	O	O	O
its	its	O	O	O	O
possible	possible	O	O	O	O
reversibility	reversibility	O	O	O	O
after	after	O	O	O	O
drug	drug	O	O	O	O
withdrawal	withdrawal	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
case-control	case-control	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
All	all	O	O	O	O
PD	pd	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
Amiens	amiens	O	O	O	O
area	area	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
invited	invited	O	O	O	O
to	to	O	O	O	O
attend	attend	O	O	O	O
a	a	O	O	O	O
cardiologic	cardiologic	O	O	O	O
assessment	assessment	O	O	O	O
including	including	O	O	O	O
transthoracic	transthoracic	O	O	O	O
echocardiography	echocardiography	O	O	O	O
.	.	O	O	O	O

Thirty	thirty	O	O	O	O
PD	pd	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
participated	participated	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
second	second	O	O	O	O
echocardiography	echocardiography	O	O	O	O
was	was	O	O	O	O
performed	performed	O	O	O	O
(	(	O	O	O	O
median	median	O	O	O	O
interval	interval	O	O	O	O
:	:	O	O	O	O
13	13	O	O	O	O
months	months	O	O	O	O
)	)	O	O	O	O
after	after	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
withdrawal	withdrawal	O	O	O	O
(	(	O	O	O	O
n=10	n=10	O	O	O	O
patients	patients	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Controls	controls	O	O	O	O
were	were	O	O	O	O
age-	age-	O	O	O	O
and	and	O	O	O	O
sex-matched	sex-matched	O	O	O	O
non-PD	non-pd	O	O	O	O
patients	patients	O	O	O	O
referred	referred	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
cardiology	cardiology	O	O	O	O
department	department	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Compared	compared	O	O	O	O
to	to	O	O	O	O
controls	controls	O	O	O	O
,	,	O	O	O	O
aortic	aortic	O	O	OTHERS	I
regurgitation	regurgitation	O	O	OTHERS	I
(	(	O	O	O	O
OR	or	O	O	O	O
:	:	O	O	O	O
3.1	3.1	O	O	O	O
;	;	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
IC	ic	O	O	O	O
:	:	O	O	O	O
1.1	1.1	O	O	O	O
-	-	O	O	O	O
8.8	8.8	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
mitral	mitral	O	DISEASE	OTHERS	I
regurgitation	regurgitation	O	DISEASE	OTHERS	I
(	(	O	O	O	O
OR	or	O	O	O	O
:	:	O	O	O	O
10.7	10.7	O	O	O	O
;	;	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
IC	ic	O	O	O	O
:	:	O	O	O	O
2.1	2.1	O	O	O	O
-	-	O	O	O	O
53	53	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
more	more	O	O	O	O
frequent	frequent	O	O	O	O
in	in	O	O	O	O
PD	pd	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
(	(	O	O	O	O
tricuspid	tricuspid	O	O	O	O
:	:	O	O	O	O
NS	ns	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
affected	affected	O	O	O	O
valves	valves	O	O	O	O
(	(	O	O	O	O
n=2.4+/-0.7	n=2.4+/-0.7	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
sum	sum	O	O	O	O
of	of	O	O	O	O
regurgitation	regurgitation	O	O	O	O
grades	grades	O	O	O	O
(	(	O	O	O	O
n=2.8+/-1.09	n=2.8+/-1.09	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
higher	higher	O	O	O	O
(	(	O	O	O	O
p=0.008	p=0.008	O	O	O	O
and	and	O	O	O	O
p=0.006	p=0.006	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
.	.	O	O	O	O

Severity	severity	O	O	O	O
of	of	O	O	O	O
regurgitation	regurgitation	O	O	O	O
was	was	O	O	O	O
not	not	O	O	O	O
correlated	correlated	O	O	O	O
with	with	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
cumulative	cumulative	O	O	O	O
dose	dose	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
restrictive	restrictive	O	O	O	O
pattern	pattern	O	O	O	O
of	of	O	O	O	O
valvular	valvular	O	O	OTHERS	I
regurgitation	regurgitation	O	O	OTHERS	I
,	,	O	O	O	O
suggestive	suggestive	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
12/30	12/30	O	O	O	O
(	(	O	O	O	O
40	40	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
patients	patients	O	O	O	O
including	including	O	O	O	O
two	two	O	O	O	O
with	with	O	O	O	O
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Pergolide	pergolide	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
discontinued	discontinued	O	O	O	O
in	in	O	O	O	O
10	10	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
valvular	valvular	O	DISEASE	OTHERS	I
heart	heart	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
,	,	O	O	O	O
resulting	resulting	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
lower	lower	O	O	O	O
regurgitation	regurgitation	O	O	O	O
grade	grade	O	O	O	O
(	(	O	O	O	O
p=0.01	p=0.01	O	O	O	O
)	)	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
second	second	O	O	O	O
transthoracic	transthoracic	O	O	O	O
echocardiography	echocardiography	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
two	two	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
heart	heart	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
returned	returned	O	O	O	O
to	to	O	O	O	O
nearly	nearly	O	O	O	O
normal	normal	O	O	O	O
clinical	clinical	O	O	O	O
examination	examination	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
study	study	O	O	O	O
supports	supports	O	O	O	O
the	the	O	O	O	O
high	high	O	O	O	O
frequency	frequency	O	O	O	O
of	of	O	O	O	O
restrictive	restrictive	O	O	O	O
valve	valve	O	O	OTHERS	I
regurgitation	regurgitation	O	O	OTHERS	I
in	in	O	O	O	O
PD	pd	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
pergolide	pergolide	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
reveals	reveals	O	O	O	O
that	that	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
improvement	improvement	O	O	O	O
is	is	O	O	O	O
usual	usual	O	O	O	O
when	when	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
is	is	O	O	O	O
converted	converted	O	O	O	O
to	to	O	O	O	O
non-ergot	non-ergot	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
agonists	agonists	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

